-
- 抗原 See all IL-4 (IL4) 抗体
- IL-4 (IL4) (Interleukin 4 (IL4))
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- This IL-4 antibody is un-conjugated
-
应用范围
- Immunohistochemistry (IHC)
- 特异性
- Recognises both natural and recombinant human IL-4
- 纯化方法
- Ion exchange chromatography
- 过滤
- 0.22 μm filtered
- 免疫原
- Recombinant human IL-4,Myeloma X63/AG.8653 x Balb/c spleen cells
- 克隆位点
- B-S4
- 亚型
- IgG1 kappa
- Top Product
- Discover our top product IL4 Primary Antibody
-
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 状态
- Liquid
- 缓冲液
- Phosphate-buffered saline. Sterile-filtered through 0.22 μm. Carrier and preservative free
- 储存液
- Without preservative
- 储存条件
- 4 °C
- 储存方法
- Stable at +2-8°C for 12 months. For longer storage freeze aliquots.
-
-
Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 179, Issue 7, pp. 4874-83, (2007) (PubMed).
: "Autocrine production of interleukin-4 and interleukin-10 is required for survival and growth of thyroid cancer cells." in: Cancer research, Vol. 66, Issue 3, pp. 1491-9, (2006) (PubMed).
: "Human CD4+CD25+ regulatory T lymphocytes inhibit lipopolysaccharide-induced monocyte survival through a Fas/Fas ligand-dependent mechanism." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 177, Issue 9, pp. 6540-7, (2006) (PubMed).
: "Streptococcal preparation OK-432 promotes fusion efficiency and enhances induction of antigen-specific CTL by fusions of dendritic cells and colorectal cancer cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 178, Issue 1, pp. 613-22, (2006) (PubMed).
: "Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 11, Issue 21, pp. 7891-900, (2005) (PubMed).
: "IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 9, pp. 5467-77, (2004) (PubMed).
: "Thyroid cancer resistance to chemotherapeutic drugs via autocrine production of interleukin-4 and interleukin-10." in: Cancer research, Vol. 63, Issue 20, pp. 6784-90, (2003) (PubMed).
: "
-
Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 179, Issue 7, pp. 4874-83, (2007) (PubMed).
-
- 抗原
- IL-4 (IL4) (Interleukin 4 (IL4))
- 别名
- IL-4 (IL4 产品)
- 别名
- IL4 antibody, IL-4 antibody, BCGF-1 antibody, BCGF1 antibody, BSF-1 antibody, BSF1 antibody, Il-4 antibody, Il4e12 antibody, IL2 antibody, interleukin 4 antibody, IL4 antibody, Il4 antibody
- 途径
- JAK/STAT Signaling, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response, Proton Transport, Activated T Cell Proliferation
-